- About Us
- Career Center
- Nano-Social Network
- Nano Consulting
- My Account
May 7th, 2007
NanoViricides Inc. saw its stock jump 8 percent Monday after the company announced positive results of recent tests of its antiviral drug designed to treat bird flu.
The stock, which trades on the Pink Sheets market as NNVC.pk, rose 9 cents to close at $1.19 a share Monday.
NanoViricides, based at 135 Wood St., recently carried out in vitro testing of its FluCide-HP — an antiviral drug delivered by nanotechnology — in Vietnam.
|Related News Press|
Nanometrics Announces Upcoming Investor Events July 28th, 2015
Gold-diamond nanodevice for hyperlocalised cancer therapy: Gold nanorods can be used as remote controlled nanoheaters delivering the right amount of thermal treatment to cancer cells, thanks to diamond nanocrystals used as temperature sensors August 1st, 2015
Take a trip through the brain July 30th, 2015
Sol-gel capacitor dielectric offers record-high energy storage July 30th, 2015
Interviews/Book Reviews/Essays/Reports/Podcasts/Journals/White papers
Thin films offer promise for ferroelectric devices: Researchers at Tokyo Institute of Technology demystify the ferroelectric properties observed in hafnium-oxide-based thin films, revealing a potentially useful device material August 3rd, 2015
Shaping the hilly landscapes of a semi-conductor nanoworld August 1st, 2015
Solid state physics: Quantum matter stuck in unrest August 1st, 2015
Self-assembling, biomimetic membranes may aid water filtration August 1st, 2015
Kalam: versatility personified August 1st, 2015